NEW YORK (GenomeWeb News) – Nanosphere said after the close of the market Wednesday that its third-quarter revenues increased 56 percent year over year driven by consumables sales.

The Northbrook, Ill.-based molecular diagnostics firm reported revenues of $865,000 for the three-month period ended Sept. 30, compared to $556,000 for the third quarter of 2011. While the sales figures were up sharply year over year, the firm fell far short of the consensus Wall Street estimate for revenues of $1.7 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.